Target Details
| UniProt AC | P51617 |
|---|---|
| Gene Symbol | IRAK1 |
| Protein Name | Interleukin-1 receptor-associated kinase 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00531 (Death) PF00069 (Pkinase) |
Summary
- Multi-target molecules 312
- Clinical molecules 15
- Avg pChEMBL 6.84
KEGG Pathways (20)
- Alcoholic liver disease
- Chagas disease
- Coronavirus disease - COVID-19
- Epstein-Barr virus infection
- Hepatitis B
- Herpes simplex virus 1 infection
- Human immunodeficiency virus 1 infection
- Leishmaniasis
- Lipid and atherosclerosis
- MAPK signaling pathway
- Measles
- NF-kappa B signaling pathway
- Neurotrophin signaling pathway
- Pathogenic Escherichia coli infection
- Pertussis
- Salmonella infection
- Toll-like receptor signaling pathway
- Toxoplasmosis
- Tuberculosis
- Yersinia infection
Active Molecules (312)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
OXRQZPOYHSRCIB
|
6.4 | IC50 | 3 | — | |
CEOQQVRJCFJERM
|
6.3 | IC50 | 2 | — | |
OMZCMEYTWSXEPZ
|
6.3 | Kd | 43 | Yes | |
PQMBTEFIJYDBHA
|
6.3 | IC50 | 2 | — | |
AHYTYKPDDJPJKK
|
6.3 | Ki | 2 | — | |
AIQDZMUPVYDVLB
|
6.3 | Ki | 48 | — | |
BSFNGHCTZDCQBF
|
6.3 | Ki | 93 | — | |
CHTMRWQLNNRRFJ
|
6.3 | Ki | 70 | — | |
FAIHBCXQSBIRIL
|
6.3 | Ki | 22 | — | |
GDYZFFBMSBDTAA
|
6.3 | Ki | 60 | — | |
UYJNQQDJUOUFQJ
|
6.3 | Ki | 68 | — | |
BFBOXYLGKAPSFY
|
6.3 | Ki | 2 | — | |
QKXDICQFNATVHN
|
6.3 | IC50 | 3 | — | |
TUAJTUKIIJXVON
|
6.3 | IC50 | 3 | — | |
BIIVYFLTOXDAOV
|
6.3 | Kd | 82 | Yes | |
AIYIKSZSMWXXLB
|
6.3 | IC50 | 2 | — | |
BTHHTUIURXXDQK
|
6.3 | IC50 | 2 | — | |
DIVBAVIPIJCFQU
|
6.3 | IC50 | 2 | — | |
FASAXWZUGXWYCH
|
6.3 | IC50 | 2 | — | |
FYPLNZXUWFDWFV
|
6.3 | IC50 | 2 | — | |
GKSLYGBWVIREPH
|
6.3 | IC50 | 2 | — | |
HCVYZVCMHVIECU
|
6.3 | IC50 | 2 | — | |
IOAFUECVQSRNGN
|
6.3 | IC50 | 2 | — | |
IQMFQXFGETWXJL
|
6.3 | IC50 | 2 | — | |
JXSBVAFKVRLTBE
|
6.3 | IC50 | 2 | — | |
JYXZRFURTZGRAR
|
6.3 | IC50 | 2 | — | |
JZUXTONNGLAGNS
|
6.3 | IC50 | 2 | — | |
KDEVAODGQITDKB
|
6.3 | IC50 | 2 | — | |
KJGJMKXKURZKFH
|
6.3 | IC50 | 2 | — | |
LKLKMYFYHDFSLS
|
6.3 | IC50 | 2 | — | |
OWGPCYDHMUISML
|
6.3 | IC50 | 2 | — | |
RPMCQWGLLTVGAY
|
6.3 | IC50 | 2 | — | |
RWRVISCWYIIYAX
|
6.3 | IC50 | 2 | — | |
SDMRQHXJQFKDHV
|
6.3 | IC50 | 2 | — | |
UTBPPDSKJWJGTI
|
6.3 | IC50 | 2 | — | |
VLQGQOAWWLQXOZ
|
6.3 | IC50 | 2 | — | |
VZTDACMGWBXNRQ
|
6.3 | IC50 | 2 | — | |
WHFKPHNLHTXXRK
|
6.3 | IC50 | 2 | — | |
WJPDPEBXKRAWLO
|
6.3 | IC50 | 2 | — | |
WMPBJANDRBQKLJ
|
6.3 | IC50 | 2 | — | |
WUGZCFHBTBZAKK
|
6.3 | IC50 | 2 | — | |
WWNTVVYKRQBYEQ
|
6.3 | IC50 | 2 | — | |
XHWNTEWYWFMZBL
|
6.3 | IC50 | 2 | — | |
XMDZLJRPNPTNNM
|
6.3 | IC50 | 2 | — | |
XRKNHCDVUQOHPG
|
6.3 | IC50 | 2 | — | |
XSSXUEALEQDOGI
|
6.3 | IC50 | 2 | — | |
YLQBHUZSTBTNCJ
|
6.3 | IC50 | 2 | — | |
ZGPAYCQEDZYSFA
|
6.3 | IC50 | 2 | — | |
ZOPDRRJPLQTJDQ
|
6.3 | IC50 | 2 | — | |
ZRJZIWDFCSJDNF
|
6.3 | IC50 | 2 | — |